Announcements

Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General Manager-Finance, Mr.Sachin Salvi and the Marketing Team at our Corporate Office, on Wednesday, February 15, 2017 by 11.00 AM, and a likely visit to one of our franchisees thereafter.

Intimation about meeting of Mr. Balvinder Singh, Analyst from Canara HSBC, with our Vice-President (Operations), Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi, at our office by 5.00 PM on 09-02-2017.

Intimation about conference call on 31-01-2017 about the unaudited financial results for the quarter / nine-months ended December 31, 2016.

Intimation of Outcome of the Board Meeting held on January 28, 2017 .(i) To declare an interim dividend of Rs. 5/- per share and fixing of 09-02-2017 as record date for payment of dividend and (ii) To approve the unaudited financial results (Stand alone and Consolidated) for the quarter / nine months ended December 31, 2016.

Intimation about meeting of Mr. Jack and Mr. Mohan of Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani at our office by 3.00 PM on 08-02-2017.

Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2016, and consider paying interim dividend if any.

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr.Shaleen Kumar of UBS Securities India, at our office by 10.00 A.M. on 26-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Ms. Amisha Vora & Mr. Dilip Bhat, Joint Managing Directors, and Mr. Vishal & Mr. Shankar, Co-Heads-Equities, of Prabhudas Lilladher Pvt. Ltd. at our office by 3.00 P.M. on 22-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sandeep Kothari and Mr. Rahul Gupta, of Fidelity International at our office by 9.00 A.M. on 23-12-2016

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in Spark Healthcare Conference 2016, in BKC, Mumbai on 13-12-2016.

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr. Sarath Sathkumara, Managing Director, Taiyo Pacific Partners, USA, at our office, by 4.30 P.M. on 20-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Arindam Bhattacharjee, Partner & Portfolio Manager, Mr. Paul Ballantyne, Partner & Portfolio Manager, and Mr. Sebastian Peters, Portfolio Manager of Genesis Investment Management Ltd., UK, at our office, by 9.00 A.M. on 13-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sunil Asnani, Portfolio Manager of Matthews Asia of Matthews International Capital Management LLC, at our Office, at Navi Mumbai by 9.30 A.M.on 08-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Krishna Kumar, Portfolio Manager of Eastsprings Investments (Singapore) Ltd., a wholly owned subsidiary of Prudential Plc of UK, at Hotel Trident, BKC, Mumbai, by 8.00 A.M. on 07-12-2016.

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani at the IDFC Annual Investor Conference at “The Taj Lands End”, Mumbai, on 16-11-2016 where he would talk briefly about the Company, its nature of business and growth, and would also meet various investors / analysts attending the conference.

Intimation about meeting of analysts from Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani on 02-11-2016 and visit of analysts from Phillip Capital (India) P. Ltd., to our Central Processing Laboratory at Navi Mumbai on 02-11-2016.

Intimation about conference call on 25-10-2016 about the unaudited financial results for the quarter / half-year ended September 30, 2016.

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter / half-year ended September 30, 2016.

Intimation about Board Meeting scheduled to be held on October 24, 2016, to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/six months ended 30-09-2016.

Intimation about meeting between a few investors / fund managers and our Chairman & Managing Director, Dr. A. Velumani, on Friday, September 30, 2016 at 9.00 A.M. at Hotel J W Marriott, Mumbai.

Intimation about meeting between analysts from Ventura Capital with our General Manager-Finance, Mr. Sachin Salvi on Wednesday, September 28, 2016 at 11.00 A.M. at our office at Navi Mumbai.

Intimation about meeting between a few analysts / fund managers and our Chairman & Managing Director, Dr. A. Velumani on Tuesday, September 27, 2016 at 4.00 P.M. at our Office at Navi Mumbai.

Intimation about the 16th Annual General Meeting held on September 12, 2016.

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani in a conference organised by Nomura group in UK where he had one-to-one meeting with representatives of six global fund managers.

Intimation about decision taken at the Board Meeting held on 27-08-2016 regarding sale of shares held by the Company in Thyrocare International Holding Co., Mauritius, to a relative of the Promoters.

Intimation about approval of the unaudited financial results – both Stand-alone and Consolidated – for the quarter ended June 30, 2016.

Intimation about Board Meeting scheduled to be held on July 22, 2016 to approve unaudited financial results (Stand-alone and Consolidated), for the quarter ended June 30, 2016.

Intimation about Meeting of a few analysts / fund managers with our Chairman & Managing Director at the Company’s Corporate Office at 10.00 a.m. on 24-06-2016.

Intimation about Conference call arranged by the Company on June 15, 2016 for Indian and Overseas Investors to discuss about the financial results of Quarter / Financial Year ended 31-03-2016.

Intimation about decisions taken at the Board Meeting held on June 11, 2016, about approval of the Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2015-16 and recommending a final dividend of Rs. 2.5 per share. This is in addition to two interim dividends of Rs. 3.75 each, totaling to Rs. 7.50 per share, already paid. With this, the total dividend for the year would be 100%.